Neoadjuvant therapy with ipilimumab and nivolumab for stage III malignant melanoma - a case report

被引：0
|
作者：
Hansen, I. [1 ]
Heidrich, I. [1 ]
Belz, S. [1 ]
Noebel, C. [1 ]
Geidel, G. [1 ]
Hildebrandt, L. [1 ]
Schneider, S. W. [1 ]
Gebhardt, C. [1 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Klin Dermatol & Venerol, Hamburg, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
eP096
引用
收藏
页码：87 / 88
页数：2
相关论文
共 50 条
  • [41] Neoadjuvant ipilimumab plus nivolumab in early stage colon cancer
    Chalabi, M.
    Fanchi, L. F.
    Van den Berg, J. G.
    Beets, G. L.
    Lopez-Yurda, M.
    Aalbers, A. G.
    Grootscholten, C.
    Snaebjornsson, P.
    Maas, M.
    Mertz, M.
    Nuijten, E.
    Kuiper, M.
    Kok, M.
    Van Leerdam, M. E.
    Schumacher, T. N.
    Voest, E. E.
    Haanen, J. B.
    ANNALS OF ONCOLOGY, 2018, 29 : 731 - 731
  • [42] Case of uveitis with increased electroretinographic amplitudes following Nivolumab and Ipilimumab administration for malignant melanoma
    Kato, Kumiko
    Nagashima, Ryunosuke
    Matsubara, Hisashi
    Yonekawa, Yuka
    Kashima, Yuzen
    Mizumoto, Keitaro
    Kondo, Mineo
    DOCUMENTA OPHTHALMOLOGICA, 2025,
  • [43] Adjuvant Nivolumab or Ipilimumab plus Nivolumab for Melanoma Determined by Pathological Response to a Single Dose of Neoadjuvant Nivolumab
    Khan, Tahsin M.
    Teke, Martha E.
    Karakousis, Giorgos C.
    Miura, John T.
    Brody, Robert M.
    Hernandez, Jonathan M.
    Mitchell, Tara C.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (05) : 2771 - 2772
  • [44] Ipilimumab/nivolumab/nivolumab/prednisoneVarious toxicities: case report
    Reactions Weekly, 2023, 1963 (1) : 305 - 305
  • [45] Case Report: Differential Genomics and Evolution of a Meningeal Melanoma Treated With Ipilimumab and Nivolumab
    Burgos, Remberto
    Cardona, Andres F.
    Santoyo, Nicolas
    Ruiz-Patino, Alejandro
    Cure-Casilimas, Juanita
    Rojas, Leonardo
    Ricaurte, Luisa
    Munoz, Alvaro
    Garcia-Robledo, Juan Esteban
    Ordonez, Camila
    Sotelo, Carolina
    Rodriguez, July
    Zatarain-Barron, Zyanya Lucia
    Pineda, Diego
    Arrieta, Oscar
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [46] Ipilimumab/nivolumab-induced pseudolymphoma in a patient with malignant melanoma
    Ayoubi, Noura
    Haque, Adel
    Vera, Nora
    Ma, Sophia
    Messina, Jane
    Khushalani, Nikhil
    Seminario-Vidal, Lucia
    JOURNAL OF CUTANEOUS PATHOLOGY, 2020, 47 (04) : 390 - 393
  • [47] Case Report: Neuromyelitis Optica After Treatment of Uveal Melanoma With Nivolumab and Ipilimumab
    Khimani, Karima
    Patel, Sapna P.
    Whyte, Andrew
    Al-Zubidi, Nagham
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Ipilimumab/nivolumab/pembrolizumabHepatitis: case report
    Reactions Weekly, 2020, 1834 (1) : 141 - 141
  • [49] Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report
    D. E. Meyers
    W. F. Hill
    A. Suo
    V. Jimenez-Zepeda
    T. Cheng
    N. A. Nixon
    Experimental Hematology & Oncology, 7
  • [50] Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report
    Meyers, D. E.
    Hill, W. F.
    Suo, A.
    Jimenez-Zepeda, V.
    Cheng, T.
    Nixon, N. A.
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2018, 7
12345